CareDx, Inc. ( CDNA) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDT Hello, everyone. Thank you for joining us and welcome to the CareDx Q2 2026 Earnings Call. [Operator Instructions] I will now hand ...

Highl ights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% ...

Q2 2026 Earnings Call July 30, 2026 4:30 PM EDTCompany ParticipantsCamilla Zuckero - Vice President of Investor ...

Highlights Second quarter 2026 revenue of $190.7 million decreased 11% year-over-year, reflecting a 1% decline in volume and a 9% decrease in average revenue per test year-over-year. The company is en ...

Earnings call CenterPoint Energy delivered Q2 2026 non-GAAP EPS of $0.40, reiterating full-year guidance of $1.89-$1.91 (8% growth over 2025). Management raised the 10-year capital plan by $1.2B to ...

Reflects a pre-tax gain, net of transaction costs, recognized on the sale of Neurocrine Group Limited in January 2026. Estimated income tax effect of Non-GAAP reconciling items are calculated using ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter ended June 30, 2026.

Delivered Q2 2026 revenue of $103.5 millionQ2 2026 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 32% over Q2 2025Raising ...

CFO Pyles guided Q2 2026 revenue of $364 million to $366 million and Q2 non-GAAP operating margin of 17.5% to 18.5%. CFO Pyles raised full-year FY 2026 revenue guidance to $1.499 billion to $1.503 ...

Uranium stocks rose this past week, but Cameco (CCJ) stands out from the group. The gains followed a recent nuclear power ...

A finance degree involves the management, creation, and study of money, banking, investments, assets, and liabilities. The Bachelor of Science in Finance degree prepares students for management ...